(1)
Chetan Dev; Rana Muhammad Naveed; Nur Qistina Binti Mohammed Haniff; Lavinya Vasudevan; Haider Hasnain; Jerin Xavier Polackal; Majid Ali Shah; Ayaan Rafiq Shaikh; Saja Saad; Zaid Hassan. LONG-TERM CARDIOVASCULAR OUTCOMES AND SAFETY PROFILE OF PCSK9 INHIBITORS IN HIGH-RISK POPULATIONS FOR SECONDARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A COMPREHENSIVE META-ANALYSIS OF MORTALITY, MAJOR ADVERSE CARDIAC EVENTS, AND METABOLIC IMPACT. IJHR 2024, 2 (2 (Health & Allied), 381-388. https://doi.org/10.71000/ijhr199.